SEC Form 4 · accession 0000905148-17-000429
BIOLASE, INC · BIOL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Harold C Flynn Jr.
Officer — President and CEO · Director
Period of report
Feb 18, 2017
Accepted (ET)
Mar 23, 2017 · 5:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000811240
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 18, 2017 | M | 29,761 | — | A | 96,720 | D | |
| Common StockF2 | holding | — | — | — | 35,400 | I | By Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1,F3 | — | Feb 18, 2017 | M | 29,761 | D | — | — | Common Stock | 29,761 | 1,435,000 | D |
Explanation of responses
- F1Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
- F2The common stock is held directly by the Flynn Living Trust (the "Trust"). Mr. Flynn serves as a co-trustee to the Trust and his daughter is the beneficiary of the Trust.
- F3On February 26, 2016, the reporting person was granted 59,523 restricted stock units, of which 29,762 vested on March 26, 2016 and the remaining half vested on February 18, 2017.